Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study That Switched Patients From Imatinib to Nilotinib and Then Was Followed by Treatment Cessation

ClinicalTrials.gov ID: NCT01744665

Public ClinicalTrials.gov record NCT01744665. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 4:51 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Randomized, Multicenter Study of Treatment-free Remission in Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Patients Who Achieve and Sustain MR4.5 After Switching to Nilotinib

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To evaluate molecular relapse free rates 6 months after stopping nilotinib therapy in patients who achieve MR4.5

Study identification

NCT ID
NCT01744665
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
59 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 12, 2013 (Actual)
Primary completion
Sep 28, 2018 (Actual)
Completion
Sep 29, 2018 (Actual)
Last update posted
Mar 10, 2020

2013 – 2018

United States locations

U.S. sites
54
U.S. states
25
U.S. cities
47
Facility City State ZIP Site status
University of Alabama Comprehensive Cancer Center University of Alabama (8) Birmingham Alabama 35294 —
Banner MD Anderson Cancer Center Banner MD Anderson (2) Gilbert Arizona 85234 —
Scottsdale Healthcare/TGen Clinical Research Service SC Scottsdale Arizona 85258 —
Highlands Oncology Group Fayetteville Arkansas 72703 —
City of Hope National Medical Center Dept of Oncology Duarte California 91010 3000 —
Compassionate Care Research Group Inc CCCMG Fountain Valley California 92708 —
UC San Diego UC San Diego Cancer Ctr La Jolla California 92093-0987 —
Wilshire Oncology Medical Group Corona Cancer Center Multiple Locations California — —
Epic-Care Pleasant Hill California 94523 —
Sutter Institute for Medical Research Oncology/Hematology Sacramento California 95816-5199 —
St Joseph Heritage Healthcare Santa Rosa California 94503 —
Rocky Mountain Cancer Centers USOR Boulder Colorado 80304 —
Florida Cancer Specialists DeptofFloridaCancerSpecialists Fort Myers Florida 33901 —
MD Anderson Cancer Center - Orlando Cancer Center Orlando Florida 32806 —
H Lee Moffitt Cancer Center and Research Institute H. Lee Moffitt Cancer Ctr (67) Tampa Florida 33612 —
Stroger Cook County Hospital Division of Hematology & Onc Chicago Illinois 60612 —
University of Chicago Medical Center Chicago Illinois 60637 —
University of Iowa Hospitals and Clinics Holden Comprehensive Cancer Ct Iowa City Iowa 52242 —
University of Kansas Hospital and Medical Center Clinical Research Center Kansas City Kansas 66160 —
Cancer Center of Kansas Wichita Kansas 67214-3728 —
Christus Schumpert Health System Shreveport Louisiana 71101 —
Michigan State University / Breslin Cancer Center Breslin Cancer Center (3) Lansing Michigan — —
Billings Clinic Billings Clinic (8) Billings Montana Montana 59101 —
Hackensack University Medical Center John Theurer Cancer Center Hackensack New Jersey 07601 —
Hematology Oncology Associates of Northern New Jersey PA Dept of Hem-Onc of Northern NJ Morristown New Jersey 07962 —
Memorial Sloan Kettering Memorial Sloan Kettering (63) New York New York 10017 —
Weill Cornell Medical Center Dept. of Oncology New York New York 10021 —
Columbia University Medical Center Herbert Irving Pavilion New York New York 10032 —
University of Rochester Medical Center Rochester New York 14642 —
Montefiore Medical Center Montefiore Medicial Center The Bronx New York 10467 —
Westchester Medical Center NY Medical College Valhalla New York 10595 —
Duke University Medical Center Duke University Med Ctr Durham North Carolina 27710 —
Carolina Oncology Specialists, PC Hickory North Carolina 28602 —
Wake Forest University Health Sciences Hematology and Oncology Winston-Salem North Carolina 27157 —
Ohio State Comprehensive Cancer Center/James Cancer Hospital OSU Medical Center Columbus Ohio 43210 —
Northwest Cancer Specialists Compass Oncology -BKM Portland Oregon 97210 —
University of South Carolina-Hollings Cancer Center Medical University of SC Columbia South Carolina 29203 —
Tennessee Oncology Dept. of Centennial Medical Nashville Tennessee 37203 —
Vanderbilt Univeristy Ingram Cancer Center (10) Nashville Tennessee 37232 —
Hendrick Cancer Center Hendricks Cancer Center Abilene Texas 79601 —
Texas Oncology Texas Oncology - McAllen Dallas Texas 75246 —
Texas Oncology Texas Oncology - Plano West Dallas Texas 75246 —
Texas Oncology P A Texas Oncology - Midland Dallas Texas 75251 —
University of Texas Medical Branch SC Galveston Texas 77555-1188 —
Oncology Consultants Oncology Consultants, P.A. Houston Texas 77024 —
The Methodist Hospital Cornell University Houston Texas 77030 —
South Texas Cancer Center- McAllen McAllen Texas 78503 —
Brooke Army Medical Center Brooke Army Medical San Antonio Texas 78234 —
Waco Cancer and Research Center Waco Texas 76712 —
University of Utah / Huntsman Cancer Institute Huntsman Cancer Center Salt Lake City Utah 84103 —
University of Virginia Charlottesville Virginia 22908 —
Kadlec Clinic Hematology and Oncology SC Kennewick Washington 99336 —
West Virginia University/ Mary Babb Randolph Cancer Center Mary Babb Randolph Cancer Ctr Morgantown West Virginia 26506 —
Medical College of Wisconsin Med College of WI Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01744665, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 10, 2020 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01744665 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →